This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ratner, M. Pfizer settles largest ever fraud suit for off-label promotion. Nat Biotechnol 27, 961–962 (2009). https://doi.org/10.1038/nbt1109-961
Issue Date:
DOI: https://doi.org/10.1038/nbt1109-961
This article is cited by
-
Crossing the line
Nature Biotechnology (2010)
-
Unbalanced reporting of benefits and harms in abstracts on rofecoxib
European Journal of Clinical Pharmacology (2010)